Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems.
The Liu Group is recruiting an individual to work on research and projects focused on the diagnosis and management of infections in people with cancer and other immunocompromising conditions, including recipients of cellular therapy. There is one-year of funding for the position.
The successful applicant will work on research with Dr. Catherine Liu focused on optimizing the diagnosis and management of infections in people with cancer and other immunocompromising conditions. The individual will work on projects aimed at systems and quality improvement and collaborate with the Antimicrobial Stewardship and Infection Prevention programs. The individual will also participate in clinical trials involving novel therapeutics for prevention and treatment of infections in immunocompromised individuals. Opportunities exist to contribute to writing of manuscripts as co- or lead author, grants, and presenting research at scientific meetings. The individual will also attend on Fred Hutchinson Cancer Center Infectious Disease Consult Service, and as needed on the University of Washington’s Solid Organ Transplant Service provide direct clinical care as part of specialty care team. Fred Hutchinson Cancer Center provides a challenging academic and supportive multi-disciplinary research environment, and the Research Associate will be able to take full advantage of training, education, and mentorship opportunities offered through Fred Hutch
MINIMUM QUALIFICATIONS:
PREFERRED QUALIFICATIONS:
The annual base salary range for this position is from $80,172 to $149,968, and pay offered will be based on experience and qualifications.
Although Fred Hutch is not sponsoring most H-1B visas at this time, candidates who already hold an H-1B sponsored by another organization and are currently in the U.S. may be eligible for this position.
Fred Hutchinson Cancer Center offers employees a comprehensive benefits package designed to enhance health, well-being, and financial security. Benefits include medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, onsite health clinic, tuition reimbursement, paid vacation (12-22 days per year), paid sick leave (12-25 days per year), paid holidays (13 days per year), and paid parental leave (up to 4 weeks).
Fred Hutchinson Cancer Center unites comprehensive care and advanced research to provide the latest cancer treatment options and accelerate discoveries that prevent, treat and defeat cancer and infectious diseases worldwide.
An independent, nonprofit organization, Fred Hutch also serves as UW Medicine’s cancer program. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
Fred Hutchinson Cancer Center will accelerate the development, evaluation, and use of new cancer discoveries and treatments and will offer patients greater access to clinical trials, bringing research and clinical care closer together. For current patients the superior care you have come to expect from us will continue uninterrupted. For example, as part of the transition to Fred Hutch there will be no changes to your doctor or care team. Over the longer term, this update to our structure will enable us to improve patients’ care experiences and increase integration across your care team.
Fred Hutch will focus on integrating teams and operations over the coming weeks and months but you will see some new changes coming soon.
During the transition and afterward, high-quality patient care, research and operations will continue uninterrupted. Seattle Children's, an original SCCA alliance partner, will work in close partnership with Fred Hutchinson Cancer Center to advance breakthroughs in adult and pediatric oncology.
Fred Hutch is an independent, nonprofit organization that also serves as the cancer program for UW Medicine. This relationship allows for enhanced care coordination with one of the world’s leading integrated health systems.
![]()
Learn more about UW Medicine
Learn more about our research at Fred Hutch